Spots Global Cancer Trial Database for Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
Official Title: Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer : a Pilot Study
Study ID: NCT01336231
Conditions
Interventions
Study Description
Brief Summary: Longitudinal study nonrandomized, multicenter observational descriptive monitoring patients treated with anti-angiogenic for metastatic kidney cancer
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre François BACLESSE, Caen, Calvados, France
Hôpital Georges Pompidou, Paris, Ile de France, France
Centre Henri Becquerel, Rouen, Seine Maritime, France
CHU, Rouen, Seine Maritime, France
CHU, Strasbourg, , France
Institut Gustave Roussy, Villejuif, , France
Contact Details
Name: Florence JOLY-LOBBEDEZ, PD
Affiliation: Centre François Baclesse
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
